EQUITY RESEARCH MEMO

Occhem Labs

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Occhem Labs, LLC is a US-based contract research organization (CRO) founded in 2014, specializing in custom synthesis and sourcing of small organic molecules for pre-clinical research. Serving pharmaceutical, agricultural, and biotechnology sectors, the company offers services including natural products isolation, semi-synthesis, and development of drug-like compounds and building blocks. It has developed a niche expertise in the synthesis of Vitamin K metabolites and derivatives. As a private, pre-clinical stage CRO, Occhem Labs generates revenue through service contracts rather than drug development pipelines, positioning it as a stable but moderate-growth entity in the outsourced research market.

Upcoming Catalysts (preview)

  • Q3 2026Expansion of Vitamin K metabolite synthesis capabilities70% success
  • Q4 2026Strategic partnership with a major pharmaceutical company40% success
  • Q2 2026New ISO certification or quality accreditation85% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)